Leo A. van Grunsven

15.0k total citations · 1 hit paper
148 papers, 7.3k citations indexed

About

Leo A. van Grunsven is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Leo A. van Grunsven has authored 148 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Hepatology, 57 papers in Molecular Biology and 53 papers in Epidemiology. Recurrent topics in Leo A. van Grunsven's work include Liver physiology and pathology (72 papers), Liver Disease Diagnosis and Treatment (51 papers) and Organ Transplantation Techniques and Outcomes (20 papers). Leo A. van Grunsven is often cited by papers focused on Liver physiology and pathology (72 papers), Liver Disease Diagnosis and Treatment (51 papers) and Organ Transplantation Techniques and Outcomes (20 papers). Leo A. van Grunsven collaborates with scholars based in Belgium, Germany and United Kingdom. Leo A. van Grunsven's co-authors include Inge Mannaerts, Danny Huylebroeck, Kristin Verschueren, Geert Berx, Erik Bruyneel, Mustapha Najimi, Étienne Sokal, Frans van Roy, Petra Vermassen and Marc Mareel and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Leo A. van Grunsven

143 papers receiving 7.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion

2001 1.1k citations Kristin Verschueren, Leo A. van Grunsven et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Leo A. van Grunsven Belgium	46	3.6k	2.1k	1.8k	1.4k	1.4k	148	7.3k
Jean S. Campbell United States	46	3.3k 0.9×	2.9k 1.4×	1.6k 0.9×	1.2k 0.8×	1.9k 1.4×	110	7.4k
Isabel Fabregat Spain	53	4.8k 1.3×	2.3k 1.1×	1.4k 0.8×	2.4k 1.7×	1.1k 0.8×	168	8.8k
George C. Yeoh Australia	42	2.2k 0.6×	2.3k 1.1×	1.2k 0.7×	808 0.6×	1.8k 1.3×	157	5.7k
Rachel A. Ridgway United Kingdom	29	3.5k 1.0×	808 0.4×	887 0.5×	2.5k 1.8×	1.2k 0.8×	45	6.3k
Christine Perret France	48	5.4k 1.5×	1.3k 0.6×	798 0.5×	1.8k 1.3×	1.4k 1.0×	158	8.7k
Krista Rombouts United Kingdom	37	1.3k 0.3×	1.6k 0.8×	1.8k 1.0×	519 0.4×	958 0.7×	89	4.2k
Kinji Asahina Japan	30	1.6k 0.4×	1.7k 0.8×	1.2k 0.7×	496 0.4×	1.1k 0.8×	71	4.0k
Yunfei Yuan China	51	4.8k 1.3×	1.6k 0.8×	1.1k 0.6×	1.7k 1.2×	809 0.6×	187	8.2k
Masakiyo Sakaguchi Japan	41	3.2k 0.9×	693 0.3×	517 0.3×	737 0.5×	919 0.7×	195	5.5k
Kazuhito Naka Japan	40	4.0k 1.1×	609 0.3×	722 0.4×	2.0k 1.5×	500 0.4×	92	7.3k

Countries citing papers authored by Leo A. van Grunsven

Since Specialization

Citations

This map shows the geographic impact of Leo A. van Grunsven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leo A. van Grunsven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leo A. van Grunsven more than expected).

Fields of papers citing papers by Leo A. van Grunsven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leo A. van Grunsven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leo A. van Grunsven. The network helps show where Leo A. van Grunsven may publish in the future.

Co-authorship network of co-authors of Leo A. van Grunsven

This figure shows the co-authorship network connecting the top 25 collaborators of Leo A. van Grunsven. A scholar is included among the top collaborators of Leo A. van Grunsven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leo A. van Grunsven. Leo A. van Grunsven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mol, Hans, Weronika Kowalczyk, Leticia Sansores-García, et al.. (2025). Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation. Journal of Hepatology. 83(5). 1142–1155. 1 indexed citations

Boon, Ruben, Joris Vriens, Leo A. van Grunsven, et al.. (2023). Osmolar Modulation Drives Reversible Cell Cycle Exit and Human Pluripotent Cell Differentiation via NF‐κВ and WNT Signaling. Advanced Science. 11(7). e2307554–e2307554. 5 indexed citations

Chai, Yoke Chin, San Kit To, Samantha Zaunz, et al.. (2023). Spatially Self‐Organized Three‐Dimensional Neural Concentroid as a Novel Reductionist Humanized Model to Study Neurovascular Development. Advanced Science. 11(5). e2304421–e2304421. 8 indexed citations

Kowalczyk, Weronika, Mardelle Atkins, Hanne Hillen, et al.. (2022). Hippo signaling instructs ectopic but not normal organ growth. Science. 378(6621). eabg3679–eabg3679. 43 indexed citations

Smet, Vincent De, Nathalie Eysackers, Georg Halder, et al.. (2021). Initiation of hepatic stellate cell activation extends into chronic liver disease. Cell Death and Disease. 12(12). 1110–1110. 46 indexed citations

Kumar, Manoj, Burak Toprakhisar, Matthias Van Haele, et al.. (2021). A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model. Biomaterials. 276. 121006–121006. 26 indexed citations

Smedt, Jonathan De, Irene Talón, Burak Toprakhisar, et al.. (2021). PU.1 drives specification of pluripotent stem cell-derived endothelial cells to LSEC-like cells. Cell Death and Disease. 12(1). 84–84. 29 indexed citations

Manco, Rita, Laure‐Alix Clerbaux, Stefaan Verhulst, et al.. (2019). Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury. Journal of Hepatology. 70(6). 1180–1191. 64 indexed citations

Verboven, Elisabeth, Leen Van Huffel, Iván M. Moya, et al.. (2019). Comparison of the Opn-CreER and Ck19-CreER Drivers in Bile Ducts of Normal and Injured Mouse Livers. Cells. 8(4). 380–380. 12 indexed citations

10.

Smedt, Eva De, Ken Maes, Stefaan Verhulst, et al.. (2017). Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression. Cancer Research. 78(5). 1155–1168. 30 indexed citations

11.

Najar, Mehdi, Laurent Dollé, Emerence Crompot, et al.. (2017). Isolation and Characterization of Bone Marrow Mesenchymal Stromal Cell Subsets in Culture Based on Aldehyde Dehydrogenase Activity. Tissue Engineering Part C Methods. 24(2). 89–98. 4 indexed citations

12.

Najar, Mehdi, Hussein Fayyad‐Kazan, Wissam H. Faour, et al.. (2016). Human hepatic stellate cells and inflammation: A regulated cytokine network balance. Cytokine. 90. 130–134. 11 indexed citations

13.

Mannaerts, Inge, Sofia Batista Leite, Stefaan Verhulst, et al.. (2015). The Hippo pathway effector YAP controls mouse hepatic stellate cell activation. Journal of Hepatology. 63(3). 679–688. 304 indexed citations

14.

Struys, Tom, Tom Dresselaers, Michael Hodenius, et al.. (2013). In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes. Biomaterials. 35(3). 1015–1024. 23 indexed citations

15.

Best, Jan, Laurent Dollé, Paul Manka, et al.. (2013). Role of liver progenitors in acute liver injury. Frontiers in Physiology. 4. 258–258. 38 indexed citations

16.

Beneden, Katrien Van, Caroline Geers, Marina Pauwels, et al.. (2013). Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis. Toxicology and Applied Pharmacology. 271(2). 276–284. 52 indexed citations

17.

Mannaerts, Inge, Nele Nuytten, Vera Rogiers, et al.. (2009). Chronic Administration of Valproic Acid Inhibits Activation of Mouse Hepatic Stellate Cells in Vitro and in Vivo. Hepatology. 51(2). 603–614. 96 indexed citations

18.

Srahna, Mohammed, Leo A. van Grunsven, Jacques Remacle, & Peter Vandenberghe. (2005). CTLA‐4 interacts with STAT5 and inhibits STAT5‐mediated transcription. Immunology. 117(3). 396–401. 10 indexed citations

19.

Collart, Clara, Jacques Remacle, Silvia M.L. Barabino, et al.. (2005). Smicl is a novel Smad interacting protein and cleavage and polyadenylation specificity factor associated protein. Genes to Cells. 10(9). 897–906. 12 indexed citations

20.

Rossel, Mireille, Andrea Pasini, Isabelle Schuffenecker, et al.. (1997). Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations. Oncogene. 14(3). 265–275. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact